tradingkey.logo
tradingkey.logo
Suchen

MiMedx Group Inc

MDXG
Zur Watchlist hinzufügen
3.930USD
+0.120+3.15%
Handelsschluss 06/26, 16:00ETKurse um 15 Minuten verzögert
582.01MMarktkapitalisierung
18.91KGV TTM

mehr Informationen über MiMedx Group Inc Unternehmen

MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.

MiMedx Group Inc Informationen

BörsenkürzelMDXG
Name des UnternehmensMiMedx Group Inc
IPO-datumAug 20, 2007
CEOCapper (Joseph H)
Anzahl der mitarbeiter837
WertpapierartOrdinary Share
GeschäftsjahresendeAug 20
Addresse1775 W Oak Commons Court, Ne
StadtMARIETTA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl30062
Telefon17706519100
Websitehttps://mimedx.com/
BörsenkürzelMDXG
IPO-datumAug 20, 2007
CEOCapper (Joseph H)

Führungskräfte von MiMedx Group Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
310.29K
-190.25%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
284.25K
+28.78%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
263.68K
+19.31%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
108.51K
+46.92%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
93.15K
-28.52%
Mr. William Frank (Butch) Hulse, IV
Mr. William Frank (Butch) Hulse, IV
Chief Administrative Officer, General Counsel
Chief Administrative Officer, General Counsel
--
--
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. K. Todd Newton
Mr. K. Todd Newton
Independent Director
Independent Director
--
--
Marty Sutter ,
Marty Sutter ,
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
310.29K
-190.25%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
284.25K
+28.78%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
263.68K
+19.31%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
108.51K
+46.92%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
93.15K
-28.52%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von MiMedx Group Inc?

Die fünf größten Anteilseigner von MiMedx Group Inc sind: Mr. Joseph H. (Joe) Capper

Wie viele Institutionen halten Anteile an MiMedx Group Inc (MDXG)?

Mit Stand vom 2026Q1 halten 462 Institutionen Anteile an MiMedx Group Inc, mit einem Gesamtmarktwert von etwa 116.77M, was 78.40% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 6172968.00 gestiegen.

Was ist die größte Einnahmequelle von MiMedx Group Inc?

Am 2026Q1 erzielte das Geschäft mit Advanced Wound Care für MiMedx Group Inc den höchsten Umsatz in Höhe von 276.33M, was 66.01% des Gesamtumsatzes entspricht.
KeyAI